FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 333:878-879 September 28, 1995 Number 13 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Ochs, A.

To the Editor: Ochs et al. (May 4 issue)¹ reported their experience using transjugular intrahepatic portosystemic stent shunts to control refractory ascites. The shunts were successfully placed in all 50 study patients, and 74 percent had total remission of ascites within three months. However, 9 of 18 patients in Child–Pugh class B and 20 of 32 in class C died within the follow-up period of 426±333 days (mean ±SD). Many shunts became occluded or stenosed, and many patients had hepatic encephalopathy after the procedure. On the basis of their uncontrolled prospective study, the authors suggest that the procedure is effective . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.